A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : LMWH

Search Conditions:
Search Keyword : LMWH
Search Method : Exact match.
Research Area:

Abbreviation: LMWH
Appearance Frequency: 4136 time(s)
Long forms: 25

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
low molecular weight heparin
(4086 times)
Vascular Diseases
(931 times)
VTE (928 times)
UFH (801 times)
DVT (554 times)
1982 A low molecular weight heparin compared with unfractionated heparin.
low molecular heparin
(10 times)
(2 times)
NCAM (2 times)
polySia (2 times)
polySTs (2 times)
1992 [Prevention of thromboembolic complications in surgery].
low-molecular-weight heparin derivative
(6 times)
(2 times)
fMLP (1 time)
GAGs (1 time)
LST (1 time)
1999 Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells.
low molecular weight fractions of heparin
(4 times)
(1 time)
anti-Xa (1 time)
APTT (1 time)
ATH (1 time)
1983 Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis.
low-molecular-weight hydrogel
(4 times)
(3 times)
DEX-P (1 time)
FTIR (1 time)
MGC (1 time)
2007 Structure and properties of low molecular weight amphiphilic peptide hydrogelators.
LMWH group
(3 times)
Thoracic Diseases
(1 time)
ACT (1 time)
MICS (1 time)
PVST (1 time)
2007 Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery.
low weight molecular heparin
(2 times)
Allergy and Immunology
(1 time)
AF (1 time)
CGA (1 time)
OAC (1 time)
2016 The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation.
low-molecular-weight heparin or heparinoid
(2 times)
Internal Medicine
(1 time)
CI (2 times)
DVT (1 time)
RR (1 time)
2007 Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles.
low-molecular-weight hyaluronan
(2 times)
(2 times)
HMWH (2 times)
CD44 (1 time)
HA (1 time)
2017 CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia.
10  low-MW-heparins
(2 times)
Biomedical Research
(1 time)
S-NACH (1 time)
UFH (1 time)
2018 Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway.
11  enoxaparin--low-molecular-weight heparin
(1 time)
(1 time)
DEXA (1 time)
MRI (1 time)
PPO (1 time)
2014 Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy.
12  LMW heparins
(1 time)
Vascular Diseases
(1 time)
CS (1 time)
CV (1 time)
UH (1 time)
1990 Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay.
13  LMWH treatment
(1 time)
(1 time)
IL-6 (1 time)
MBP (1 time)
PE (1 time)
2012 Protective effect of low-molecular-weight heparin on pancreatic encephalopathy in severe acute pancreatic rats.
(1 time)
Biomedical Engineering
(1 time)
LDHs (1 time)
SMC (1 time)
2010 Enhanced effects of low molecular weight heparin intercalated with layered double hydroxide nanoparticles on rat vascular smooth muscle cells.
15  LMWH-p
(1 time)
(1 time)
DVT (1 time)
2014 Administration of enoxaparin 24h after total knee arthroplasty: safer for bleeding and equally effective for deep venous thrombosis prevention.
16  low molecular weight fractions
(1 time)
(1 time)
--- 1994 [Instantaneous clearances: standard heparin versus low molecular weight heparin].
17  Low molecular weight heparin nanoparticles
(1 time)
(1 time)
DOX (1 time)
GA (1 time)
HPC (1 time)
2017 Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
18  low molecular weight heparin parenteral anticoagulant
(1 time)
Economics, Medical
(1 time)
VKA (1 time)
VTE (1 time)
2019 Total costs of treating venous thromboembolism: implication of different cost perspectives in a Danish setting.
19  Low Molecular Weight Heparin prophylaxis
(1 time)
Vascular Diseases
(1 time)
CAT (1 time)
CCC (1 time)
MP (1 time)
2016 Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy.
20  Low Molecular Weight Hydrogels
(1 time)
Biocompatible Materials
(1 time)
LMWHs (1 time)
2020 New injectable self-assembled hydrogels that promote angiogenesis through a bioactive degradation product.
21  low-molecular-weight analogue
(1 time)
(1 time)
--- 1993 Low-molecular-weight heparin (LMWH): influence on blood lipids in patients on chronic haemodialysis.
22  low-molecular-weight forms
(1 time)
(1 time)
FXa (1 time)
2005 The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors.
23  low-molecular-weight-- heparins being
(1 time)
(1 time)
--- 2005 [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
24  lower molecular weight
(1 time)
(1 time)
UFH (1 time)
1996 [New developments in anticoagulation with heparin; a short review.].
25  ultra-low-molecular-weight heparin
(1 time)
Vascular Diseases
(1 time)
s.c (1 time)
2013 Anticoagulant and Antithrombotic Actions of AVE5026, an Enriched Anti-Xa Hemisynthetic Ultra-Low-Molecular-Weight Heparin.